Jamie L Adams, Taylor L Myers, Emma M Waddell, Kelsey L Spear, Ruth B Schneider
{"title":"远程医疗:神经退行性疾病的宝贵工具。","authors":"Jamie L Adams, Taylor L Myers, Emma M Waddell, Kelsey L Spear, Ruth B Schneider","doi":"10.1007/s13670-020-00311-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>The prevalence of neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD), is rising as the global population ages. Access to specialist care, which improves outcomes, is insufficient and disease-related disability makes in-person physician visits burdensome. Telehealth is one potential means for improving access to care. The purpose of this manuscript is to review recent publications on telemedicine in AD and PD.</p><p><strong>Recent findings: </strong>Telemedicine is feasible in AD and PD and acceptable to patients and their caregivers. Compared with in-person visits, telemedicine reduces visit-associated travel and time. Telemedicine can be used for rehabilitative therapies, to administer cognitive tests, and to support caregivers. Access to telemedicine results in changes in patient care including medication adjustments and referrals for therapies and supports.</p><p><strong>Summary: </strong>The use of telemedicine in AD and PD stands to decrease burden on patients and increase access to specialty care. Barriers to the expansion of telemedicine care include lack of widespread broadband access, state licensure requirements, and inconsistent reimbursement. More outcomes-based prospective telemedicine studies are needed.</p>","PeriodicalId":38089,"journal":{"name":"Current Geriatrics Reports","volume":"9 2","pages":"72-81"},"PeriodicalIF":1.1000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13670-020-00311-z","citationCount":"33","resultStr":"{\"title\":\"Telemedicine: A valuable tool in neurodegenerative diseases.\",\"authors\":\"Jamie L Adams, Taylor L Myers, Emma M Waddell, Kelsey L Spear, Ruth B Schneider\",\"doi\":\"10.1007/s13670-020-00311-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose of review: </strong>The prevalence of neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD), is rising as the global population ages. Access to specialist care, which improves outcomes, is insufficient and disease-related disability makes in-person physician visits burdensome. Telehealth is one potential means for improving access to care. The purpose of this manuscript is to review recent publications on telemedicine in AD and PD.</p><p><strong>Recent findings: </strong>Telemedicine is feasible in AD and PD and acceptable to patients and their caregivers. Compared with in-person visits, telemedicine reduces visit-associated travel and time. Telemedicine can be used for rehabilitative therapies, to administer cognitive tests, and to support caregivers. Access to telemedicine results in changes in patient care including medication adjustments and referrals for therapies and supports.</p><p><strong>Summary: </strong>The use of telemedicine in AD and PD stands to decrease burden on patients and increase access to specialty care. Barriers to the expansion of telemedicine care include lack of widespread broadband access, state licensure requirements, and inconsistent reimbursement. More outcomes-based prospective telemedicine studies are needed.</p>\",\"PeriodicalId\":38089,\"journal\":{\"name\":\"Current Geriatrics Reports\",\"volume\":\"9 2\",\"pages\":\"72-81\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2020-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s13670-020-00311-z\",\"citationCount\":\"33\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Geriatrics Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13670-020-00311-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/3/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Geriatrics Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13670-020-00311-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/3/14 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
Telemedicine: A valuable tool in neurodegenerative diseases.
Purpose of review: The prevalence of neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD), is rising as the global population ages. Access to specialist care, which improves outcomes, is insufficient and disease-related disability makes in-person physician visits burdensome. Telehealth is one potential means for improving access to care. The purpose of this manuscript is to review recent publications on telemedicine in AD and PD.
Recent findings: Telemedicine is feasible in AD and PD and acceptable to patients and their caregivers. Compared with in-person visits, telemedicine reduces visit-associated travel and time. Telemedicine can be used for rehabilitative therapies, to administer cognitive tests, and to support caregivers. Access to telemedicine results in changes in patient care including medication adjustments and referrals for therapies and supports.
Summary: The use of telemedicine in AD and PD stands to decrease burden on patients and increase access to specialty care. Barriers to the expansion of telemedicine care include lack of widespread broadband access, state licensure requirements, and inconsistent reimbursement. More outcomes-based prospective telemedicine studies are needed.
期刊介绍：
This journal aims to offer in-depth review articles on the most recent innovative publications in geriatrics and gerontology. By providing clear, insightful contributions by international experts, the journal intends to serve clinicians and researchers involved in the diagnosis, management, treatment, prevention, and study of patients affected by age-related conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as the age-related change in cognitive function, the influence of genetics on neurodegenerative disorders, and traumatic brain injury and dementia. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board of more than 20 members reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. We also provide commentaries from well-known figures in the field.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
